These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32898457)

  • 1. Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Vural Keskinler M; Mutlu HH; Sirin A; Erkalma Senates B; Colak Y; Tuncer I; Oguz A
    Metab Syndr Relat Disord; 2021 Feb; 19(1):26-31. PubMed ID: 32898457
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
    Vongsuvanh R; George J; McLeod D; van der Poorten D
    J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of visceral adiposity index with serum aminotransferase and nonalcoholic fatty liver disease in patients with sleep apnea].
    Qi J; Lin Q; Lin X; Chen X
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(42):3420-3. PubMed ID: 26813130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
    Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
    Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
    Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up.
    Xu C; Ma Z; Wang Y; Liu X; Tao L; Zheng D; Guo X; Yang X
    Liver Int; 2018 Dec; 38(12):2294-2300. PubMed ID: 30099825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.
    Petta S; Amato MC; Di Marco V; Cammà C; Pizzolanti G; Barcellona MR; Cabibi D; Galluzzo A; Sinagra D; Giordano C; Craxì A
    Aliment Pharmacol Ther; 2012 Jan; 35(2):238-47. PubMed ID: 22117531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
    World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients.
    Díez-Rodríguez R; Ballesteros-Pomar MD; Calleja-Fernández A; González-De-Francisco T; González-Herráez L; Calleja-Antolín S; Cano-Rodríguez I; Olcoz-Goñi JL
    Rev Esp Enferm Dig; 2014 Dec; 106(8):522-8. PubMed ID: 25544409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study.
    Li Q; Wang L; Wu J; Wang J; Wang Y; Zeng X
    BMJ Open; 2022 Mar; 12(3):e058517. PubMed ID: 35314476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis.
    Ismaiel A; Jaaouani A; Leucuta DC; Popa SL; Dumitrascu DL
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
    J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
    Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome.
    Gu D; Ding Y; Zhao Y; Miao S; Qu Q
    Lipids Health Dis; 2018 May; 17(1):101. PubMed ID: 29734946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral adiposity index is associated with premature ejaculation inversely: a cross-sectional study.
    Cakir SS; Ozcan L; Besiroglu H; Dursun M; Polat EC; Otunctemur A; Ozbek E
    Aging Male; 2018 Sep; 21(3):206-210. PubMed ID: 29338524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral Adiposity Index Levels in Patients with Hypothyroidism.
    Pekgor S; Duran C; Kutlu R; Solak I; Pekgor A; Eryilmaz MA
    J Natl Med Assoc; 2018 Dec; 110(6):606-613. PubMed ID: 30129492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.